[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fuVswrx6g9-HIslleRNr1qaBK4YjMAyunTQ4nynpakMo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":46,"rows":53},"Arkansas Children's Hospital Research Institute",[4],120,false,35,0,18864,2,111,[14,17,20,23,26,29,31,33],{"name":15,"count":16},"Healthy",32,{"name":18,"count":19},"Asthma",11,{"name":21,"count":22},"Insulin Resistance",5,{"name":24,"count":25},"Obesity",4,{"name":27,"count":28},"Eosinophilic Esophagitis",3,{"name":30,"count":28},"Pregnancy",{"name":32,"count":11},"Hypertension",{"name":34,"count":11},"Food Allergy",[36,41],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT05875571","Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement","2025-05","Ketorolac",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT07148739","Ensuring Access to Optimal Therapy in CF: The ENACT Study","2030-12","Elexacaftor \u002F Ivacaftor \u002F Tezacaftor",[47,48,49,50,51,52],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[54,77,102,129,155,179,207,232,258],{"intervention":45,"totalTrials":55,"cells":56},1,{"EARLY_PHASE1":57,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":65,"NA":75},{"trials":58,"activeCount":9},[],{"trials":60,"activeCount":9},[],{"trials":62,"activeCount":9},[],{"trials":64,"activeCount":9},[],{"trials":66,"activeCount":55,"soonestReadout":44},[67],{"nctId":42,"briefTitle":43,"status":68,"phases":69,"primaryCompletion":44,"completion":44,"start":70,"enrollment":71,"conditions":72,"interventions":74},"RECRUITING",[51],"2025-06-10",100,[73],"Cystic Fibrosis (CF)",[45],{"trials":76,"activeCount":9},[],{"intervention":40,"totalTrials":55,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":85,"PHASE4":87,"NA":100},{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[],{"trials":88,"activeCount":55,"soonestReadout":39},[89],{"nctId":37,"briefTitle":38,"status":68,"phases":90,"primaryCompletion":39,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":99},[51],"2025-06","2024-02-05",18,[95,96,97,98],"IUD","Healthy Female","Contraception","IUD Insertion Complication",[40],{"trials":101,"activeCount":9},[],{"intervention":103,"totalTrials":55,"cells":104},"saline",{"EARLY_PHASE1":105,"PHASE1":107,"PHASE2":109,"PHASE3":123,"PHASE4":125,"NA":127},{"trials":106,"activeCount":9},[],{"trials":108,"activeCount":9},[],{"trials":110,"activeCount":9},[111],{"nctId":112,"briefTitle":113,"status":114,"phases":115,"completion":116,"start":117,"enrollment":118,"conditions":119,"interventions":121},"NCT00556361","Use of Ketamine Prior to Cardiopulmonary Bypass in Children","COMPLETED",[49],"2007-11","2004-07",24,[120],"Ventricular Septal Defect",[103,122],"ketamine",{"trials":124,"activeCount":9},[],{"trials":126,"activeCount":9},[],{"trials":128,"activeCount":9},[],{"intervention":130,"totalTrials":55,"cells":131},"pravastatin",{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":147,"PHASE3":149,"PHASE4":151,"NA":153},{"trials":133,"activeCount":9},[],{"trials":135,"activeCount":9},[136],{"nctId":137,"briefTitle":138,"status":139,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":146},"NCT00571194","Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients","TERMINATED",[48],"2009-05","2007-09",7,[145],"End Stage Renal Disease",[130],{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[],{"intervention":156,"totalTrials":55,"cells":157},"Lansoprazole",{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":171,"PHASE3":173,"PHASE4":175,"NA":177},{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[162],{"nctId":163,"briefTitle":164,"status":114,"phases":165,"primaryCompletion":166,"completion":166,"start":167,"enrollment":93,"conditions":168,"interventions":170},"NCT00458614","Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis",[48],"2007-04","2006-06",[169],"Cystic Fibrosis",[156],{"trials":172,"activeCount":9},[],{"trials":174,"activeCount":9},[],{"trials":176,"activeCount":9},[],{"trials":178,"activeCount":9},[],{"intervention":180,"totalTrials":11,"cells":181},"Ketamine",{"EARLY_PHASE1":182,"PHASE1":184,"PHASE2":186,"PHASE3":192,"PHASE4":194,"NA":196},{"trials":183,"activeCount":9},[],{"trials":185,"activeCount":9},[],{"trials":187,"activeCount":9},[188],{"nctId":112,"briefTitle":113,"status":114,"phases":189,"completion":116,"start":117,"enrollment":118,"conditions":190,"interventions":191},[49],[120],[103,122],{"trials":193,"activeCount":9},[],{"trials":195,"activeCount":9},[],{"trials":197,"activeCount":9},[198],{"nctId":199,"briefTitle":200,"status":114,"phases":201,"primaryCompletion":202,"completion":203,"start":167,"enrollment":93,"conditions":204,"interventions":206},"NCT00598195","Ketamine Pharmacokinetics in Children Having Heart Surgery",[52],"2009-01","2009-12",[205],"C.Surgical Procedure; Cardiac",[180],{"intervention":208,"totalTrials":55,"cells":209},"MDI",{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":218,"NA":220},{"trials":211,"activeCount":9},[],{"trials":213,"activeCount":9},[],{"trials":215,"activeCount":9},[],{"trials":217,"activeCount":9},[],{"trials":219,"activeCount":9},[],{"trials":221,"activeCount":9},[222],{"nctId":223,"briefTitle":224,"status":114,"phases":225,"primaryCompletion":226,"completion":227,"start":228,"enrollment":118,"conditions":229,"interventions":231},"NCT00574405","Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy",[52],"2010-03","2011-03","2005-04",[230],"Diabetes Mellitus",[208],{"intervention":233,"totalTrials":55,"cells":234},"Bethanechol",{"EARLY_PHASE1":235,"PHASE1":237,"PHASE2":239,"PHASE3":241,"PHASE4":243,"NA":245},{"trials":236,"activeCount":9},[],{"trials":238,"activeCount":9},[],{"trials":240,"activeCount":9},[],{"trials":242,"activeCount":9},[],{"trials":244,"activeCount":9},[],{"trials":246,"activeCount":9},[247],{"nctId":248,"briefTitle":249,"status":250,"phases":251,"primaryCompletion":252,"completion":252,"start":253,"enrollment":254,"conditions":255,"interventions":257},"NCT05299008","The Effect of Bethanechol on Tracheobronchomalacia","UNKNOWN",[],"2024-06-30","2022-08-11",20,[256],"Tracheobronchomalacia",[233],{"intervention":259,"totalTrials":55,"cells":260},"Methylcobalamin",{"EARLY_PHASE1":261,"PHASE1":263,"PHASE2":265,"PHASE3":267,"PHASE4":269,"NA":271},{"trials":262,"activeCount":9},[],{"trials":264,"activeCount":9},[],{"trials":266,"activeCount":9},[],{"trials":268,"activeCount":9},[],{"trials":270,"activeCount":9},[],{"trials":272,"activeCount":9},[273],{"nctId":274,"briefTitle":275,"status":114,"phases":276,"primaryCompletion":277,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},"NCT00692315","Treating Oxidative Stress in Children With Autism",[52],"2007-06","2007-12","2006-09",40,[282],"Autistic Disorder",[259]]